NATCOPHARM.NS Cash Flow
NATCO Pharma Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 6 years on file
(FY2020-21 to FY2025-26)
· fetched 2026-08-23 23:38
| Line item | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | ₹46.50 Cr. | ₹849.10 Cr. | ₹1,211.60 Cr. | ₹1,696.80 Cr. | ₹1,768.30 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | ₹-5.30 Cr. | ₹-477.10 Cr. | ₹-1,032.70 Cr. | ₹-1,414.50 Cr. | ₹-2,142.90 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | ₹34.80 Cr. | ₹-363.00 Cr. | ₹-246.90 Cr. | ₹-210.70 Cr. | ₹297.50 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | ₹9.30 Cr. | ₹11.80 Cr. | ₹6.50 Cr. | ₹-22.00 Cr. | ₹156.00 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | ₹85.30 Cr. | ₹20.80 Cr. | ₹-61.50 Cr. | ₹49.60 Cr. | ₹78.90 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | ₹25.80 Cr. | ₹111.10 Cr. | ₹131.90 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from NATCOPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).